Amiram Eldor

Amiram Eldor's AcademicInfluence.com Rankings

Amiram Eldor

Philosophy

#8344

World Rank

#11701

Historical Rank

Logic

#5376

World Rank

#6770

Historical Rank

philosophy Degrees

Amiram Eldor

Biology

#11278

World Rank

#14663

Historical Rank

Immunology

#724

World Rank

#746

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Amiram Eldor's Degrees

Masters Medicine Tel Aviv University
PhD Immunology Tel Aviv University

Why Is Amiram Eldor Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Amiram Eldor's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. (1998) (2131)
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. (1999) (1459)
Increased frequency of genetic thrombophilia in women with complications of pregnancy. (1999) (943)
Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. (2002) (669)
Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. (2004) (483)
The hypercoagulable state in thalassemia. (2002) (460)
Subcutaneous Enoxaparin Once or Twice Daily Compared with Intravenous Unfractionated Heparin for Treatment of Venous Thromboembolic Disease (2001) (357)
Structural roles of acetylcholinesterase variants in biology and pathology. (1999) (345)
Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. (1992) (322)
Thromboembolism in patients with the 'lupus'-type circulating anticoagulant. (1984) (321)
A single genetic origin for a common Caucasian risk factor for venous thrombosis. (1997) (250)
Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study (2003) (249)
Binding of thrombin to subendothelial extracellular matrix. Protection and expression of functional properties. (1989) (226)
Effects of irradiation on the release of growth factors from cultured bovine, porcine, and human endothelial cells. (1989) (201)
Increased Frequency of Genetic Thrombophilia in Women With Complications of Pregnancy (1999) (196)
Severe Preeclampsia and High Frequency of Genetic Thrombophilic Mutations (2000) (193)
Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix. (1990) (187)
Phosphatidylserine in the outer leaflet of red blood cells from β‐thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes (1993) (170)
Recovery of prostacyclin production by de-endothelialized rabbit aorta. Critical role of neointimal smooth muscle cells. (1981) (169)
Long term follow‐up after splenectomy performed for immune thrombocytopenic purpura (ITP) (2003) (164)
Pathologic Features of the Placenta in Women With Severe Pregnancy Complications and Thrombophilia (2001) (157)
Thrombin immobilized to extracellular matrix is a potent mitogen for vascular smooth muscle cells: nonenzymatic mode of action. (1990) (155)
High incidence of relapses in thrombotic thrombocytopenic purpura. Clinical study of 38 patients. (1987) (155)
Parameters of red blood cell aggregation as correlates of the inflammatory state. (2001) (144)
Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species. (1987) (143)
High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss (2000) (143)
In‐vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with β‐thalassaemia major (1997) (140)
Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias. (2001) (137)
A chronic hypercoagulable state in patients with β‐thalassaemia major is already present in childhood (1999) (125)
Genetic Hypofibrinolysis in Complicated Pregnancies (2001) (122)
Edta‐dependent pseudothrombocytopenia: A clinical study of 18 patients and a review of the literature (1991) (121)
The Inhibitory Effect of Heparin and Related Glycosaminoglycans on Neutrophil Chemotaxis (1984) (121)
Efficacy and safety of a prothrombin complex concentrate (Octaplex) for rapid reversal of oral anticoagulation. (2004) (118)
Third‐Trimester Unexplained Intrauterine Fetal Death Is Associated With Inherited Thrombophilia (2001) (113)
The role of the leech in medical therapeutics. (1996) (112)
Anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells. (2002) (111)
Increased Procoagulant Activity of Red Blood Cells from Patients with Homozygous Sickle Cell Disease and β-Thalassemia (1996) (110)
Circulating megakaryocytes: Delivery of large numbers of intact, mature megakaryocytes to the lungs (1993) (106)
Thrombophilia, Thrombosis and Pregnancy (2001) (104)
Activation, processing and trafficking of extracellular heparanase by primary human fibroblasts. (2002) (103)
ARP, A Peptide Derived from the Stress-Associated Acetylcholinesterase Variant, Has Hematopoietic Growth Promoting Activities (2001) (93)
Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients. (1996) (92)
Enhanced aggregability of red blood cells of beta-thalassemia major patients. (1996) (90)
Prediction of haemorrhagic diathesis in thrombocytopenia by mean platelet volume. (1982) (88)
Complex regulation of acetylcholinesterase gene expression in human brain tumors (2002) (86)
In vivo platelet activation in beta-thalassemia major reflected by increased platelet-thromboxane urinary metabolites. (1991) (85)
Clinical and Therapeutic Experience in 712 Israeli Patients with Idiopathic Thrombocytopenic Purpura (1994) (83)
Therapy and prevention of thrombotic thrombocytopenic purpura during pregnancy: A clinical study of 16 pregnancies (1996) (82)
The antiproliferative effect of interferon and the mitogenic activity of growth factors are independent cell cycle events. Studies with vascular smooth muscle cells and endothelial cells. (1985) (80)
Human Osteogenesis Involves Differentiation-Dependent Increases in the Morphogenically Active 3′ Alternative Splicing Variant of Acetylcholinesterase (1999) (79)
Use of low molecular weight heparin for prophylaxis and treatment of thromboembolism in pregnancy (1992) (76)
The effect of streptozotocin diabetes on platelet function in rats. (1978) (72)
Heparanase expression in human leukemias is restricted to acute myeloid leukemias. (2002) (71)
Degradation of sulfated proteoglycans in the subendothelial extracellular matrix by human platelet heparitinase. (1984) (70)
Degranulating mast cells secrete an endoglycosidase that degrades heparan sulfate in subendothelial extracellular matrix. (1990) (68)
Platelet interaction with the extracellular matrix produced by cultured endothelial cells: a model to study the thrombogenicity of isolated subendothelial basal lamina. (1982) (68)
The stress-associated acetylcholinesterase variant AChE-R is expressed in human CD34(+) hematopoietic progenitors and its C-terminal peptide ARP promotes their proliferation. (2002) (65)
The changing course of thrombotic thrombocytopenic purpura and modern therapy. (1993) (65)
The effect of radiation on prostacycliln (PG2) productnio by cultured endothelial cells (1983) (64)
Monoclonal anti-endothelial cell antibodies from a patient with Takayasu arteritis activate endothelial cells from large vessels. (1999) (64)
Runx1/AML1 in leukemia: disrupted association with diverse protein partners. (2002) (61)
Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications. (2002) (61)
Enoxaparin can be Used Safely in Patients with Severe Thrombocytopenia due to Intensive Chemotherapy Regimens (2004) (60)
Immature human megakaryocytes produce nuclear-associated acetylcholinesterase. (1997) (57)
IGIV-C, a novel intravenous immunoglobulin: evaluation of safety, efficacy, mechanisms of action, and impact on quality of life (2004) (54)
Platelet survival in patients with beta‐thalassemia (1989) (53)
Congenital afibrinogenemia and recurrent early abortion: a case report. (1985) (53)
Inhibition of platelet activation by tyrosine kinase inhibitors. (1992) (52)
Heparin and dextran sulfate antagonize PGI2 inhibition of platelet aggregation. (1979) (50)
Placing the newborn on the maternal abdomen after delivery increases the volume and CD34 cell content in the umbilical cord blood collected: an old maneuver with new applications. (1999) (48)
Retinal vein occlusion associated with methylenetetrahydrofolate reductase mutation. (1999) (47)
The saliva of the medicinal leech Hirudo medicinalis--II. Inhibition of platelet aggregation and of leukocyte activity and examination of reputed anaesthetic effects. (1987) (47)
A low molecular weight brain substance interacts, similarly to clonidine, with alpha 2-adrenoceptors of human platelets. (1987) (46)
A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia. (1995) (43)
Treatment of diabetic necrobiosis with aspirin and dipyridamole. (1978) (43)
The response of cord blood megakaryocyte progenitors to IL‐3, IL‐6 and aplastic canine serum varies with gestational age (1995) (43)
Increased expression of the CD11b/CD18 antigen on the surface of peripheral white blood cells in patients with ischemic heart disease: further evidence for smoldering inflammation in patients with atherosclerosis. (1999) (42)
Chinese food and platelets. (1980) (42)
Cultured endothelial cells increase their capacity to synthesize prostacyclin following the formation of a contact inhibited cell monolayer (1983) (42)
Interferon enhances prostacyclin production by cultured vascular endothelial cells. (1984) (42)
Avian hemangioma retrovirus induces cell proliferation via the envelope (env) gene. (2000) (42)
Zinc-induced platelet aggregation is mediated by the fibrinogen receptor and is not accompanied by release or by thromboxane synthesis. (1985) (41)
Platelet aggregation and coagulation inhibitors in leech saliva and their roles in leech therapy. (1996) (41)
Activated Polymorphonuclear Leukocytes and Monocytes in the Peripheral Blood of Patients with Ischemic Heart and Brain Conditions Correspond to the Presence of Multiple Risk Factors for Atherothrombosis (2000) (41)
Laparoscopic splenectomies for idiopathic thrombocytopenic purpura: Experience of sixty cases (2000) (41)
Anti-Endothelial Cell Antibodies (AECA) in Systemic Sclerosis - Increased Sensitivity using Different Endothelial Cell Substrates and Association with Other Autoantibodies (2001) (41)
Diet-induced hypercholesterolemia inhibits the recovery of prostacyclin production by injured rabbit aorta. (1982) (40)
Intracranial hemorrhage in patients with hemophilia. (1986) (39)
Heparanase activity in cultured endothelial cells (1991) (39)
The Urokinase-receptor (CD87) Is Expressed in Cells of the Megakaryoblastic Lineage (1997) (38)
Low molecular weight heparin for hickman catheter‐induced thrombosis in thrombocytopenic patients undergoing bone marrow transplantation (1992) (38)
Inhibition of platelet-derived growth factor-induced mitogenesis and tyrosine kinase activity in cultured bone marrow fibroblasts by tyrphostins. (1992) (38)
Anti-endothelial cell antibodies from patients with thrombotic thrombocytopenic purpura specifically activate small vessel endothelial cells. (2001) (37)
Perturbation of endothelial functions by ionizing irradiation: effects on prostaglandins, chemoattractants and mitogens. (1989) (37)
The effect of T-2 toxin on human platelets. (1984) (37)
Pathogenicity of human anti‐platelet factor 4 (PF4)/heparin in vivo: generation of mouse anti‐PF4/heparin and induction of thrombocytopenia by heparin (1997) (37)
The Inflammation Meter: Novel Technology to Detect the Presence of Infection/Inflammation in Patients without Leukocytosis but with Increased Leukocyte Adhesiveness/Aggregation (2000) (36)
Permanent neurological complications in patients with thrombotic thrombocytopenic purpura (1988) (34)
Heparin inhibits PGE1-sensitive adenylate cyclase and antagonizes PGE1 antiaggregating effect in human platelets. (1979) (33)
The Picture of Inflammation: A New Concept That Combines the White Blood Cell Count and Erythrocyte Sedimentation Rate into a New Hematologic Diagnostic Modality (2001) (33)
The procoagulant effect of zinc on fibrin clot formation (1985) (33)
Production and characterization of interferon from endothelial cells (1985) (32)
A chronic hypercoagulable state and life-long platelet activation in beta thalassemia major. (1993) (32)
Bilateral retinal vein occlusion associated with 5,10-methylenetetrahydrofolate reductase mutation. (1997) (32)
Clinical and therapeutic experience in 712 Israeli patients with idiopathic thrombocytopenic purpura. Israeli ITP Study Group. (1994) (32)
Merkel cell tumor in a woman with chronic lymphocytic leukemia. (1996) (32)
Role of heparanase in platelet and tumor cell interactions with the subendothelial extracellular matrix. (1987) (31)
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely III Medical Patients (2000) (31)
Prostacyclin production by arterialized autogenous venous grafts in dogs. (1981) (30)
Anti-endothelial cell antibodies in the sera of hyperprolactinemic women (1998) (30)
Down‐regulation of the CD62L antigen as a possible mechanism for neutrophilia during inflammation (1998) (30)
De novo appearance of the ph-1 chromosome in a previously monosomic bone marrow (45,XX,-6): conversion of a myeloproliferative disorder to acute myelogenous leukemia. (1975) (30)
A potent inhibitor of platelet activating factor from the saliva of the leech Hirudo medicinalis. (1992) (29)
High-Dose Intravenous γ-Globulins for Heparin-Induced Thrombocytopenia: A Prompt Response (1998) (29)
The use of low-molecular-weight heparin for the management of venous thromboembolism in pregnancy. (2002) (28)
The Erythrocyte Adhesiveness/Aggregation Test (EAAT) in the Peripheral Blood of Patients With Ischemic Heart and Brain Disease with Normal Fibrinogen Concentrations (2000) (28)
Abnormalities of Aggregation, Thromboxane A2 Synthesis, and 14C Serotonin Release in Platelets of Patients with Idiopathic Scoliosis (1983) (28)
Thrombophilia and its Treatment in Pregnancy (2001) (28)
Expansion of megakaryocyte progenitors from human umbilical cord blood using a new two‐step separation procedure (1998) (27)
Thromboplastic Activity in Amniotic Fluid During Pregnancy (1977) (27)
Different Effects of Aspirin, Dipyridamole and UD-CG 115 on Platelet Activation in a Model of Vascular Injury: Studies with Extracellular Matrix Covered with Endothelial Cells (1986) (27)
Thrombolytic therapy reduces red blood cell aggregation in plasma without affecting intrinsic aggregability. (2002) (26)
Heparan sulfate degradation in tumor cell invasion and angiogenesis. (1988) (26)
Danaparoid for cardiopulmonary bypass in patients with previous heparin‐induced thrombocytopenia (1997) (26)
The procoagulant activity of red blood cells from patients with severe preeclampsia. (1997) (25)
Selective inhibition of neutrophil activation by the subendothelial extracellular matrix: possible role in protection of the vessel wall during diapedesis. (1990) (25)
Thrombotic thrombocytopenic purpura: diagnosis, pathogenesis and modern therapy. (1998) (25)
Chronic idiopathic thrombocytopenic purpura (ITP) is a surgical disease (2001) (25)
Megakaryocyte interaction with subendothelial extracellular matrix is associated with adhesion, platelet-like shape change, and thromboxane A2 production (1985) (25)
Multifocal vascular tumors in fowl induced by a newly isolated retrovirus. (1990) (24)
Protection and Expression of Functional Properties (1989) (24)
Platelet interaction with subendothelial extracellular matrix: platelet-fibrinogen interactions are essential for platelet aggregation but not for the matrix-induced release reaction. (1985) (24)
Transient focal neurological deficits during pregnancy in carriers of inherited thrombophilia. (2000) (24)
Generation of lipid neutrophil chemoattractant by irradiated bovine aortic endothelial cells. (1988) (24)
The effects of dextran sulfate, heparin and PGE1 on adenylate cyclase activity and aggregation of human platelets. (1979) (23)
Complex host cell responses to antisense suppression of ACHE gene expression. (2001) (23)
Effects of Dipyrone on Prostaglandin Production by Human Platelets and Cultured Bovine Aortic Endothelial Cells (1983) (23)
Inherited thrombophilia and gestational vascular complications. (2003) (22)
Bile salts facilitate the absorption of heparin from the intestine. (1983) (22)
Ex vivo expansion of megakaryocyte precursors by preincubation of marrow allografts with interleukin-3 and granulocyte-macrophage colony-stimulating factor in vitro. (1995) (22)
Jaw anatomy of the blood-sucking leeches, Hirudinea Limnatis nilotica and Hirudo medicinalis, and its relationship to their feeding habits (2000) (21)
Laparoscopic splenectomy in patients with refractory or relapsing thrombotic thrombocytopenic purpura. (2001) (21)
Ex vivo expansion of megakaryocyte progenitors from cryopreserved umbilical cord blood. A potential source of megakaryocytes for transplantation. (2002) (21)
Successful pregnancies of two patients with relapsing thrombotic thrombocytopenic purpura (1989) (20)
Laparoscopic accessory splenectomy for recurrent idiopathic thrombocytopenic purpura and hemolytic anemia (2000) (20)
Highly elevated lactate dehydrogenase level in a healthy individual: A case of macro‐LDH (1997) (20)
Low molecular weight heparin for hickman catheter‐induced thrombosis in thrombocytopenic patients undergoing bone marrow transplantation (1993) (20)
High-dose intravenous gamma-globulins for heparin-induced thrombocytopenia: a prompt response. (1998) (20)
Structural properties of myosin from the particulate fraction of human blood platelets. (1983) (20)
Cytocidal effect caused by the envelope glycoprotein of a newly isolated avian hemangioma-inducing retrovirus (1989) (20)
Erythrocytosis associated with multiple cutaneous leiomyomata: report of a case with demonstration of erythropoietic activity in the tumour. (2009) (19)
Do human platelets have opiate receptors? (1980) (19)
Immunohistochemical studies with antibodies to myosins from the cytoplasm and membrane fraction of human blood platelets (2004) (19)
Disseminated visceral fusariosis treated with amphotericin B-phospholipid complex. (1993) (19)
Megakaryocyte maturation is associated with expression of the CXC chemokine connective tissue‐activating peptide CTAP III (2000) (18)
Intestinal Absorption of Low Molecular Weight Heparin in Animals and Human Subjects (2000) (18)
Heparin-induced thrombocytopenia--pathogenesis and treatment. (1993) (18)
Altered structural and functional properties of myosins, from platelets of idiopathic scoliosis patients (1989) (18)
Low molecular weight heparin in the prophylaxis and treatment of disseminated intravascular coagulation in acute promyelocytic leukemia (1995) (18)
Activation of platelet heparitinase by tumor cell-derived factors. (1991) (18)
ENTERAL ADMINISTRATION OF INSULIN IN THE RAT (1981) (18)
Abnormal platelet functions in beta thalassaemia. (1978) (17)
The effect of radiation on prostacyclin (PGI2) production by cultured endothelial cells. (1983) (17)
Adhesion, spreading and fragmentation of human megakaryocytes exposed to subendothelial extracellular matrix: a scanning electron microscopy study. (1986) (17)
Envelope glycoprotein of avian hemangioma retrovirus induces a thrombogenic surface on human and bovine endothelial cells (1990) (17)
Platelet Abnormalities in Muscular Dystrophy (1983) (17)
Platelet-tumor cell interaction with the subendothelial extracellular matrix: relationship to cancer metastasis. (1985) (17)
Heparin‐induced thrombocytopenia and fatal thrombosis in a patient with activated protein C resistance (1995) (16)
Aberrant congenital dyserythropoietic anemia with negative acidified serum tests and features of thalassemia in a Kurdish family. (1978) (16)
Recovery of prostacyclin capacity of irradiated endothelial cells and the protective effect of vitamin C. (1987) (16)
Severe Thrombotic Complications Associated with Activated Protein C Resistance Acquired by Orthotopic Liver Transplantation (2000) (16)
Successful administration of low molecular weight heparin in a patient with heparin-induced thrombocytopenia and coumarin-induced skin necrosis. (1993) (15)
Circulating megakaryocytes and platelet production in the lungs. (1990) (15)
Relapsing haemolytic anaemia of pregnancy with negative antiglobulin reaction. (2009) (15)
Activated protein C resistance and pregnancy complications. (1996) (15)
The effect of oral administration of dipyrone on the capacity of blood platelets to synthesize thromboxane A2 in man (2004) (15)
Growth characteristics of human first trimester decidual cells cultured in serum-free medium: production of prolactin, prostaglandins and fibronectin. (1984) (15)
Clinical differentiation of low molecular weight heparins. (1999) (14)
Enteral administration of heparin. (1979) (14)
A mouse model for heparin-induced thrombocytopenia. (1999) (14)
Abnormal Platelet Functions in β Thalassaemia (2009) (14)
Self-Management of Oral Anticoagulants with a Whole Blood Prothrombin-Time Monitor in Elderly Patients with Atrial Fibrillation (2002) (14)
Arachidonic metabolism and radiation toxicity in cultures of vascular endothelial cells. (1989) (14)
Characterization of the ATPase activities of myosins isolated from the membrane and the cytoplasmic fractions of human platelets. (1984) (13)
Thrombotic thrombocytopenic purpura: The israeli experience (1992) (13)
Correction: Increased Frequency of Genetic Thrombophilia in Women with Complications of Pregnancy. (1999) (12)
Measurement of platelet and megakaryocyte interaction with the subendothelial extracellular matrix. (1989) (12)
Functional, biochemical, and structural anomalies in platelets of patients with idiopathic scoliosis. (1989) (12)
Studies on fibronectin and its domains. I. Novel recombinant cell-binding domain of fibronectin--a modulator of human platelet functions. (1993) (12)
Fatal pulmonary artery thrombosis in a patient with Behçet's disease, activated protein C resistance and hyperhomocystinemia. (2000) (12)
Disseminated intravascular coagulopathy caused by acetic acid ingestion. (1993) (11)
The Effects of Crystalloid Potassium Cardioplegic Solution on Arterialized Canine Vein Grafts: Assessment of Chronic Prostacyclin Production and Histopathologic Alterations (1981) (11)
Granulocyte Transfusion Therapy (1978) (10)
6 Immune thrombocytopenic purpura in adults: clinical aspects (1998) (10)
The distribution of platelet contractile proteins in normal and streptozotocin diabetic rats. (1979) (10)
Effect of bone marrow T lymphocytes treated with CAMPATH 1G on megakaryocyte colony formation. (1993) (10)
Bleeding tendency: a practical approach in dentistry. (1999) (10)
Second‐trimester maternal serum alpha‐fetoprotein (MSAFP) iselevated in women with adverse pregnancy outcome associated with inherited thrombophilias (2001) (10)
Low molecular weight heparin stimulates megakaryocytopoiesis in bone‐marrow transplantation patients (1996) (10)
Programmed endothelial cell death induced by an avian hemangioma retrovirus is density dependent. (1996) (10)
Effects of ionizing irradiation on endothelial cell transglutaminase (1993) (10)
Tyrosine kinase blockers: new platelet activation inhibitors. (1990) (9)
Megakaryocyte interaction with subendothelial extracellular matrix is associated with adhesion, platelet-like shape change, and thromboxane A2 production. (1985) (9)
Interactions between prostacyclin metabolism and cholesteryl ester metabolism in the vascular wall. (1983) (9)
Megakaryocyte interaction with the subendothelial extracellular matrix. (1986) (9)
Increased leukocyte aggregation induced by gamma-globulin: a clue to the presence of pseudoleukopenia. (2000) (9)
Treatment of the hematological manifestations of dyskeratosis congenita (1993) (9)
Changes in the Con-A-induced redistribution pattern of lymphocytes: a possible aid in the differential diagnosis between malignant lymphoma and other diseases. (1980) (9)
Antifibrinolytic activity of human saliva components. (1980) (8)
Viral mediated gene transfer to sprouting blood vessels during angiogenesis. (2002) (8)
Hemorrhagic tendency in beta-thalassemia major. (1978) (8)
Recombinant Human Interleukin-6 Accelerates In-Virto Megakaryocytopoiesis and Platelet Recovery Post Autologous Peripheral Blood Stem Cell Transplantion (1995) (7)
Multiple myeloma terminating in lymphocytic leukemia with B‐lymphocyte membrane markers (1977) (7)
Androgen-responsive aplastic anemia in a dog. (1978) (7)
The effects of ionizing irradiation on production of thromboxane and prostacyclin by the isolated perfused rat kidney. (1988) (7)
The effect of transferrin-free serum on the utilization of iron by rabbit reticulocytes. (1970) (7)
Distribution of myosin, actin and actin-binding protein in thrombasthenic platelets. (1980) (7)
Alveolar rhabdomyosarcoma presenting as subacute intravascular coagulation. (1977) (7)
Stem cell factor (SCF) synergizes with megakaryocyte colony stimulating activity in post-irradiated aplastic plasma in stimulating human megakaryocytopoiesis (1996) (7)
Increased leukocyte aggregation induced by γ-globulin : A clue to the presence of pseudoleukopenia (2000) (7)
The effect of flow on the interaction of isolated megakaryocytes with subendothelial extracellular matrix. (1991) (7)
Injury models of the vascular endothelium: apoptosis and loss of thromboresistance induced by a viral protein. (1996) (7)
CORRELATION BETWEEN THROMBOPLASTIC ACTIVITY AND LECITHIN/SPHINGOMYELIN RATIO IN AMNIOTIC FLUID PRELIMINARY REPORT (1977) (7)
Immune thrombocytopenic purpura in adults: clinical aspects. (1998) (7)
Prevention of clot formation in cat retinal vein by systemic and subconjunctival urokinase. (1987) (7)
Detection of a Thrombolysis-Related Reduction in Red Blood Cell Adhesiveness/Aggregation Using a Simple Slide Test (2002) (7)
High-Dose Dexamethasone for Splenectomy in Patients with Idiopathic Thrombocytopenic Purpura (1998) (7)
Medicinal leeches for the salvage of a replanted digit. (1999) (7)
Megakaryocyte maturation is associated with expression of the cxc chemokine connective tissue activating peptide ctap III (2000) (6)
Warfarin therapy is feasible in CYP2C9*3 homozygous patients. (2005) (6)
Relapsing Coombs-negative haemolytic anaemia in pregnancy with haemolytic disease in the newborn. (1975) (6)
Unexplored territories in the nonsurgical patient: a look at pregnancy. (2001) (6)
Pregnancy-induced hypertension is associated with elevation of aggregability of red blood cells. (2002) (6)
Decreased Neutrophil Thromboxane A2 and Endothelial PGI2 Production in the Postoperative Period: An In Vitro Assay for Detection of Neutrophil and Plasma Dysfunction (1988) (5)
Warfarin Therapy is Feasible In CYP2C9*3 Homozygous Patients: 109 (2004) (5)
Interferon enhances phospholipase A2 activity in bovine aortic endothelial cells. (1990) (5)
Characterization of monoclonal antibodies to human platelet myosin that recognize highly conserved epitopes within the 50 kDa fragment of myosin subfragment-1. (1990) (5)
Thromboxane and Prostacyclin Production by Irradiated and Perfused Rat Kidney (1987) (5)
Successful splenectomy in May-Hegglin anomaly: report of a case with platelet kinetic studies. (1989) (5)
Maternal hemorrhagic complications following prophylactic low-dose aspirin and dipyridamole therapy. (1992) (5)
Structural and immunological properties of myosin from human platelet external and internal membranes. (1989) (4)
Acute surgical abdomen caused by thrombocytopenia in patients with acute leukemia and multiple myeloma. (1983) (4)
Heparin-induced thrombocytopenia with thrombotic sequelae: a review. (2002) (4)
Low-Molecular-Weight Heparin for the Prevention of Obstetric Complications in Women with Thrombophilias (2001) (4)
Inhibition of tissue plasminogen activators and urokinase by human saliva. (1994) (4)
Applying risk assessment models in non-surgical patients: effective risk stratification. (1999) (4)
Megakaryocyte function and dysfunction. (1989) (4)
2 Megakaryocyte function and dysfunction (1989) (4)
Heparin-prostacyclin interactions: heparin does not modify the prostacyclin induced relaxation of coronary vasculature. (1980) (4)
Hemorrhagic Tendency in β - Thalassemia Major (1979) (4)
Disseminated intravascular coagulation in two patients with histiocytic medullary reticulosis. (1984) (4)
S17.1. Enhanced aggregability of red blood cells of β-thalassemia major patients; Monitoring by computerized image analysis (1995) (3)
The effect of long-term colchicine therapy in patients with recurrent polyserositis on the capacity of blood platelets to synthesize thromboxane A2. (1983) (3)
[Fibrinolytic therapy in acute myocardial infarction]. (1982) (3)
Activated protein C resistance in a case of anterior ischemic optic neuropathy (1999) (3)
by Human Platelet Heparitinase (1984) (3)
[Pulsed high-dose dexamethasone in resistant immune thrombocytopenic purpura]. (1996) (3)
Connective tissue activating peptide III expression disappears progressively with increased dysplasia in human cervical epithelium. (2000) (3)
The effect of antibodies to human platelet membrane and cytoplasmic myosins on myosin ATPase activity and platelet aggregation. (1985) (3)
[Macroenzymes: an interesting laboratory finding, without clinical relevance]. (1997) (2)
Involvement of tyrosine kinase activity in platelet activation (1990) (2)
Recombinant human interleukin-6 accelerates in-vitro megakaryocytopoiesis and platelet recovery post autologous peripheral blood stem cell transplantation. (1995) (2)
Distribution of actin, myosin and actin binding protein in platelets of patients with hyperlipoproteinemia. (1983) (2)
[A new mutation in the prothrombin gene (G20210A) and the risk for venous and arterial thromboembolism]. (2000) (2)
Pulmonary valve stenosis and hemophilia A. Report of three cases and discussion of a possible genetic linkage. (1986) (2)
The role of activated T lymphocytes in megakaryocytopoiesis (1992) (2)
Lysosomal Enzyme Activities in Platelets of Normal Individuals and of Patients with Gaucher’s Disease (1974) (2)
[High factor VIII as a risk factor for venous thrombosis]. (2001) (2)
The fate of circulating megakaryocytes (1990) (2)
Pathogenic anti-endothelial cell antibodies: classification to anti-microvascular EC and anti-macrovascular EC antibodies. (2000) (1)
Circulating anticoagulant and recurrent deep vein thrombosis in a 12-year-old girl (1983) (1)
Heparan Sulfate Degradation in Tumor Cell Invasion and Neovascularization (1991) (1)
Granulocyte transfusion therapy: a clinical trial in patients with acute leukemia and sepsis. (1978) (1)
Inherited thrombophilia is associated with early onset preeclampsia, fetal growth restriction, fetal demise and abrubtio placentae (1998) (1)
Prophylaxis of venous thromboembolism in acute medical patients with enoxaparin An international, randomized, double-blind, placebo-controlled trial (2000) (1)
[Resistance to activated protein C--a novel cause of thrombophilia]. (1995) (1)
Ovarian hemorrhage in women with Von Willebrand's disease. A report of two cases. (1983) (1)
[Aplastic anemia following acute viral hepatitis associated with hypogammaglobulinemia--attempted treatment by bone marrow transplantation]. (1975) (1)
A novel genetic risk for adverse pregnancy outcome (1998) (1)
RELAPSING THROMBOTIC THROMBOCYTOPENIA PURPURA (TTP): A CLINICAL STUDY OF 38 PATIENTS (1987) (0)
[Editorial: Aplastic anemia--a rare complication of infectious hepatitis]. (1975) (0)
Inhibition of Heparanase Activity by Heparin and Nonanticoagulant Heparins Potential Use in Prevention of Extravasation and Dissemination of Blood‐Borne Cells a (1989) (0)
Post-irradiated canine serum (PICS-J) stimulates megakaryocyte (MK) progenitors and thrombopoiesis in-vitro (1996) (0)
[Signal transduction inhibitor--STI571--a new treatment for chronic myeloid leukemia (CML), which opens a new targeted approach to cancer therapy]. (2002) (0)
Sustained high thrombopoietin (TPO) levels in severe aplastic anemia (SAA) patients may facilitate platelet engraftment following allogeneic bone marrow transplantation (BMT) (1998) (0)
Depression of neutrophil thromboxane A2 endothelial PG12 production and endothelial damage in postoperative patients (1987) (0)
[Elective surgery and the contraceptive pill]. (1978) (0)
Antifibrinolytic activity of human saliva components. (1980) (0)
The effect and interactions of interferon and arachidonate products with vessel wall cells. (1987) (0)
PLATELET ALPHA2-ADRENERGIC RECEPTOR ABNORMALITIES IN PATIENTS WITH IDIOPATHK: SCOLIOSIS (1987) (0)
[Normal and malignant immunocytes]. (1972) (0)
Pharmaceutical compositions with content of insulin. (1984) (0)
Compositions for the prevention of plastic rejection. (1987) (0)
Low molecular weight heparin (1992) (0)
Authors' reply (1992) (0)
Subject Index Vol. 30, 2000 (2001) (0)
[Thrombotic thrombocytopenic purpura--new insights in the pathogenesis, diagnosis and modern therapy]. (2001) (0)
Prostacyclin Production By Autogenous Venous Grafts In Dogs (1981) (0)
Operation for congenital megacolon in a hemophilic patient. (1980) (0)
Megakaryocyte - vessel wall interaction (1986) (0)
Local therapeutic approach to agranulocytotic oral ulcers. (1979) (0)
Arterial Injury Alters Metabolism Of The Arterial Wall (1981) (0)
31 Classification of chronic neutrophilic leukemia: — A report of 2 patients and review of 73 cases from the literature (1997) (0)
Purification and partial characterization of the PAF antagonist from the saliva of the leech Hirudo medicinalis. (1996) (0)
A peptide cleaved from the stress associated variant form of acetylcholinesterase modulates hematopoiesis (2000) (0)
Alveolar rhabdomyosarcoma presenting as subacute intravascular coagulation Thrombosis (2004) (0)
Insulin containing pharmaceutical compositions (1984) (0)
O94 Feasibility of warfarin therapy in carriers of allelic variants of CYP2C9 (2003) (0)
Authors Index, Vol. 26, Supplement 4, 1996 (1996) (0)
[A case of Datura stramonium poisoning]. (1971) (0)
A pharmaceutical composition for oral administration of insulin (1984) (0)
Radiation toxicity in cultured endothelial cells and its effect on transglutaminase activity (1992) (0)
[The leech in modern medicine]. (1989) (0)
Contents, Vol. 89, 1993 (1993) (0)
Diet-Induced Hyperc holesterolemia Inhibits the Recovery of Prostacyclin Production by Injured Ra bbit Aorta (2007) (0)
Subjects Index, Vol. 26, Supplement 4, 1996 (1996) (0)
Contents, Vol. 33, 1992 (1992) (0)
Megakaryocyie growth factors in sera of throbocytopenic patients undergoing chemotherapy, radiotherapy or allogeneic bone marrow transplantation (1993) (0)
COAGULOPATHY IN NON‐CIRRHOTIC PORTAL FIBROSIS (1974) (0)
Contents Vol. 97, 2002 (2002) (0)
Contents Vol. 30, 2000 (2001) (0)
Perturbation of the vascular endothelium: in vitro models (1990) (0)
Title Page / Table of Contents, Vol. 26, Supplement 4, 1996 (1996) (0)
Platelet aggregation inhibitors in the saliva of the leech Hirudo medicinals (1990) (0)
Classical haemophilia in a girl (1979) (0)
Familial relapsing thrombotic micro-angiopathy in two siblings (1996) (0)
Composition for the prevention of metastasis (1987) (0)
[Editorial: The defibrination syndrome]. (1974) (0)
Subject Index, Vol. 89, 1993 (1993) (0)
The response to treatment in chronic idiopathic thrombocytopenic purpura (ITP). (1993) (0)
LOW MOLECULAR WEIGHT HEPARIN FOR HICKMAN CATHETER-INDUCED THROMBOSIS IN THROMBOCYTOPENIC PATIENTS UNDERGOING BONE MARROW TRANSPLANTATION. AUTHOR'S REP LY (1993) (0)
[Viruses and atherosclerosis]. (1989) (0)
Subject Index Vol. 97, 2002 (2002) (0)
Plasma lipase activity as a marker for intestinal absorption of heparin (1981) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Amiram Eldor?

Amiram Eldor is affiliated with the following schools:

Tel Aviv University

Amiram Eldor's Academic­Influence.com Rankings

Amiram Eldor's Degrees

Why Is Amiram Eldor Influential?

Amiram Eldor's Published Works

Published Works

What Schools Are Affiliated With Amiram Eldor?

Amiram Eldor's AcademicInfluence.com Rankings